Just two days after Novo Nordisk launched Wegovy (semaglutide 2.4 mg) in India, Eli Lilly received regulatory approval for ...

With increasing awareness about the need to manage obesity—a global epidemic—launch of weight-loss injections in India and public demand for tailored treatment, hospitals in Delhi-NCR are stepping up ...

Obesity in India is a family problem, not an individual one, with sedentary lifestyles and unhealthy diets leading to weight ...

Abdominal obesity, based on Indian guidelines, means a waist over 90cm (35 inches) for men and 80cm (31 inches) for women. Among women aged 30 to 49, nearly one in two already show signs of it.

While real-time data on how Indians are responding to these drugs is still emerging, experts say that sustained weight loss ...

New Delhi: The prevalence of early risk factors like obesity and dyslipidemia or cholesterol irregularities have jumped 50% and 18% respectively between 2019 and 2022, as per an annual health ...

Abdominal obesity, based on Indian guidelines, means a waist over 90cm (35 inches) for men and 80cm (31 inches) for women. Among women aged 30 to 49, nearly one in two already show signs of it.

Eli Lilly said the response for its blockbuster drug Mounjaro has been "positive" in India, adding that it is focusing on ...

This obesity epidemic is also disproportionately affecting certain groups in the community. Over half of American Indian and Alaska Native women are overweight. Native people were not always ...

No, don't get us wrong we are not criticising the Indian diet even one bit. It is one of the healthiest diets you can have and recommended by experts globally to lose weight and keep blood sugar ...